Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
330
datasets available to search
ShareScore release 0.7.1
Dataset results
330 results for “non-alcoholic fatty liver disease”
LPI's role in the progression of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
GEO Series GSE138946. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease (tissue validation set 2).
GEO Series GSE193080. Homo sapiens. 59 samples. Type: Expression profiling by high throughput sequencing.
Animal study to validate effects of ACOT1 silencing in Non-alcoholic Fatty Liver Disease (NAFLD)
GEO Series GSE175426. Mus musculus. 6 samples. Type: Expression profiling by array.
Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease
GEO Series GSE215196. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease (tissue validation set 1).
GEO Series GSE193066. Homo sapiens. 164 samples. Type: Expression profiling by high throughput sequencing.
Analysis of N6-methyladenosine Methylation Modification in Fructose-induced Non-alcoholic Fatty Liver Disease
GEO Series GSE185229. Mus musculus. 32 samples. Type: Expression profiling by high throughput sequencing; Methylation profiling by high throughput sequencing.
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease (derivation set).
GEO Series GSE192959. Homo sapiens. 48 samples. Type: Expression profiling by high throughput sequencing.
Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Non-alcoholic Fatty Liver Disease in Murine Fast-food Diet Model
GEO Series GSE130528. Mus musculus. 6 samples. Type: Expression profiling by array.
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease
GEO Series GSE193084. Homo sapiens. 271 samples. Type: Expression profiling by high throughput sequencing; Other.
Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03082703. IPD Sharing: NO. Countries: 0. Publications: 0.
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
ClinicalTrials.gov study NCT04099147. IPD Sharing: NO. Countries: 0. Publications: 0.
Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus
ClinicalTrials.gov study NCT03276039. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT07320456. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03791203. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06266559. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy
ClinicalTrials.gov study NCT07255781. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06727279. IPD Sharing: YES. Countries: 0. Publications: 0.
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
ClinicalTrials.gov study NCT06009250. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06218342. IPD Sharing: Not stated. Countries: 0. Publications: 0.
AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.
ClinicalTrials.gov study NCT02826525. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.